Primary Care Voice

type 2 diabetes treatment explained by a primary care physician. Dr. Kundlas discusses the evolution of type 2 diabetes treatment, highlighting the importance of individualized care and updated guidelines. 0:00 The Evolution of Diabetes Care 1:12 The Dangers of High Blood Sugar 2:08 Tailoring Treatment to the Individual 6:08 Revolutionizing Heart and Kidney Health 8:49 The Power of Continuous Glucose Monitoring Dr. Kundlas explains the shift in type 2 diabetes treatment towards a more individualized approach, emphasizing the importance of considering comorbidities and using medications that protect organs. The 2026 guidelines prioritize comprehensive care over simply lowering A1C levels. Q: Why is controlling blood sugar important? A: High blood sugar acts like a liquid razor blade, damaging blood vessels and leading to complications such as heart attacks and strokes. Q: What role does metformin play in current treatment? A: Metformin remains important but is not sufficient alone. It helps prevent the liver from producing excess glucose. Q: How have diabetes medications evolved? A: New medications not only control blood sugar but also protect the heart, kidneys, and other organs, reducing the risk of complications. Q: What should patients with heart or kidney disease consider? A: Patients with heart issues should consider GLP-1 agonists, while those with heart failure may benefit from SGLT2 inhibitors. Q: What lifestyle changes are recommended? A: Lifestyle changes such as diet, physical activity, and weight management remain foundational in diabetes management. Educational content by a board-certified primary care physician. Based on current clinical guidelines and peer-reviewed evidence. This content is for education only and does not replace medical care. Dr. Kulmeet Kundlas – Primary Care, FL Board-Certified Internist in Active Practice 25+ Years Caring for Adult Patients Focus: Diabetes, Heart, Thyroid, Obesity Education Only – Talk to Your Doctor

Why Seeing More Specialists Can Be Dangerous: The 3-Step Primary Care Prescription The script argues that modern healthcare is dangerously fragmented when patients rely on multiple specialists without a dedicated primary care doctor coordinating care, contributing to diagnostic errors that drive 32% of U.S. medical practice claims. It warns that this fragmentation is colliding with an aging “silver tsunami,” with adults over 65 projected to outnumber children by 2034, worsening chronic disease burden and costs (including $5.3 trillion annually). Citing research including Dr. Barbara Starfield and Stanford/Harvard data, it claims strong primary care access increases life expectancy by about 52 days and reduces heart attacks, strokes, cancer, disparities, duplication, and unnecessary testing, while organ-specific care adds far less. The video presents a three-step plan: secure a dedicated primary care “medical air traffic controller,” force continuity by avoiding uncoordinated urgent/ER care, and deploy preventive care using USPSTF Grade A/B recommendations, while emphasizing patient accountability for risk-factor changes.

FDA Approves First Oral PCSK9 Inhibitor: Lipfendra Explained (Who It’s For, Cost, Benefits, Myths) Dr. Kulmeet Kundlas discusses the FDA approval of the first oral PCSK9 inhibitor, Lipfendra, as a potential game changer for patients with high cholesterol who can’t reach LDL targets with current therapy. He explains how cholesterol and lipoproteins (LDL and HDL) work, why lowering LDL reduces heart attack, stroke, PAD, and death risk, and how statins and PCSK9-targeting therapy lower LDL through different mechanisms. Lipfendra is a 20 mg once-daily pill taken on an empty stomach, priced at about $310/month, and can lower LDL by roughly 56–59% with minimal side effects (e.g., diarrhea, dizziness). FDA-approved use is as add-on therapy for patients on statins not at goal, familial hypercholesterolemia, and established ASCVD; it is not a statin replacement. He addresses common myths, emphasizes lifestyle changes, and outlines likely insurance and prescribing steps. 00:00 The FDA Just Approved This — Why It Matters 01:00 From $1,400 Injection to a $310 Pill 02:04 How Cholesterol Actually Works in Your Body 03:46 Statins vs. PCSK9: Two Different Targets 04:23 Why Lowering LDL Saves Lives (The Numbers) 05:42 Why I'm Excited — and Why It's Add-On, Not Replacement 06:44 Who's a Candidate — the Three Approved Groups 08:41 How to Take It: 20mg, Empty Stomach, Wait 30 Minutes 08:59 The Molecular Redesign That Made a Pill Possible 09:32 How Much It Lowers LDL — Cost and Side Effects 10:04 5 Myths I Need to Clear Up 12:07 Your Next Steps: The 4 Hoops

Medicare GLP-1 Bridge: 7 Facts They Did not Tell You Overview Start date: July 1, 2026 End date: December 31, 2027 (18-month CMS Innovation Fund demonstration) Purpose: Expand access to anti-obesity GLP-1 medications for Medicare beneficiaries Processing: Outside Part D, centrally administered via Humana Copay: Flat $50/month per medication Covered Medications Semaglutide (Wegovy) Tirzepatide (Zepbound) Liraglutide (Saxenda)

Medicare GLP-1 Bridge Program Explained: $50 Wegovy/Zepbound, Eligibility, PA Rules, and What Happens in 2027 A board-certified primary care physician explains Medicare’s new GLP-1 “Bridge” pilot program covering weight-loss medications (Wegovy and Zepbound) with a $50 monthly copay. The program is separate from Medicare Part D coverage and will be administered by Humana.

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Best Exercise for Diabetes: When to Walk, Cardio vs Weights, and How to Lower Blood Sugar Spikes
Dr. Kulmeet Kundlas explains how many diabetics exercise incorrectly and outlines science-based strategies to control blood sugar short term and long term. He emphasizes that “muscle is medicine,” noting muscle clears about 80% of carbohydrate load and that building 10% more muscle can reduce insulin resistance by 11%. He contrasts aerobic exercise (brisk walking, treadmill, swimming, jogging) which quickly lowers glucose by reducing insulin resistance, improving insulin sensitivity for 24 hours, using an insulin-independent pathway, and increasing blood flow, with resistance training that increases GLUT4 “doors” on muscle cells and keeps them active longer. He recommends at least 150 minutes/week of uncomfortable-paced cardio plus resistance training 2–3 times/week, walking 10 minutes after major meals to blunt spikes, timing walks immediately for non-diabetics, 15 minutes after meals for prediabetics, and 30 minutes after meals for diabetics, with late afternoon/early evening providing stronger effects.

Dining Out with Diabetes: Food Sequencing, Portions & Fast-Food Swaps to Reduce Blood Sugar Spikes
This episode explains how people with diabetes can still dine out by using strategies around portion control, mindful eating, and food sequencing to reduce post-meal blood sugar spikes. It notes that typical restaurant meals average about 860 calories, 122 grams of carbs, near-zero fiber, and high sodium, and describes how high blood sugar damages blood vessels and contributes to plaque, heart attack, stroke, and limb loss. The script outlines how the food industry drives overeating through oversized portions, ultra-processing, backward sequencing (bread first), hidden sugars in sauces, unhealthy oils, additives, plastics, and high sodium, and offers counter-strategies: box half the meal, eat fiber/vegetables first then protein/fat then carbs, choose lower-sugar sauces, prioritize whole grains/legumes, avoid sugary drinks, use CGM feedback, and make fast-food swaps (e.g., lettuce wrap plus salad/apple wedges) to cut calories and carbs.

How to Reverse Diabetes With Diet — Why Fiber Is the Secret Fiber for Type 2 Diabetes Reversal: Lower A1C, Cholesterol & Heart Risk (Soluble vs Insoluble) Dr. Kulmeet Kundlas explains how increasing dietary fiber can help reverse type 2 diabetes, reduce post-meal glucose spikes, and protect blood vessels by preventing high-sugar damage to the glycocalyx that contributes to plaque, heart attack, and stroke. He contrasts a low-fiber Western diet (about 15 g/day) with recommended intake (~30–35 g/day) and describes soluble, viscous fibers (e.g., oats, barley) that slow gastric emptying, reduce spikes, and lower cholesterol by binding bile, and insoluble/fermentable fibers (e.g., beans, lentils, greens) that feed the microbiome to produce short-chain fatty acids linked to satiety, improved insulin resistance, colon health, and increased GLP-1 signaling. He offers practical targets and food examples, advises adding fiber gradually with hydration, notes medication timing concerns, and highlights fiber’s role in preventing constipation, including with GLP-1 drugs,

Carb Counting for Diabetes: Labels, Net Carbs, Plate Method, and the Rule of 500 In this live diabetes-series session, the host explains carbohydrate counting as a key survival skill for diabetes management, focusing on how carbs affect blood sugar, how to read nutrition labels (total carbs, fiber, and net carbs), and how glycemic index influences sugar spikes. The script reviews what food is made of, why carbohydrates are the body’s preferred fuel, and how insulin works in type 1 versus insulin resistance in type 2 diabetes. Practical guidance includes estimating daily calories (10/15/20 calories per pound based on activity), aiming for a balanced diet (about 50% carbs, 25% protein, 25% fat), typical carb targets per meal (women 45–60g, men 60–75g), and using the 9-inch plate/hand-portion method. It also covers common mistakes, using CGMs, and insulin dosing with the “rule of 500.”

Type 2 diabetes reversal is no longer a hope — in 2026 it is evidence-based medicine. The latest ADA guidelines confirm that diabetes remission is achievable through diet, weight loss, exercise, sleep, and stress management. In this video, Dr. Kundlas walks you through the exact pillars that put insulin resistance into reverse, why simple carbohydrates (not all carbs) drive disease, and how losing 10–30% of body weight unlocks 34–86% remission rates. This is not about a fad low carb diet or a quick fix. It is a complete diabetes management framework rooted in physiology — the kind your doctor wishes they had time to explain.